44 related articles for article (PubMed ID: 36916140)
1. Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
Ji Y; Yang K; Peng S; Chen S; Xiang B; Xu Z; Li Y; Wang Q; Wang C; Xia C; Li L; Liu X; Lu G; Yang G; Wu H
Br J Dermatol; 2018 Aug; 179(2):457-463. PubMed ID: 29603128
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus combined with glucocorticoids in the treatment of Kasabach-Merritt phenomenon in a neonate: A case report.
Cheng J; Zou Y; Fu R; Jin P; Huang M; Wu Z; Bai H; Huang X; Yuan H
Medicine (Baltimore); 2024 Apr; 103(14):e37706. PubMed ID: 38579031
[TBL] [Abstract][Full Text] [Related]
3. Cost and effectiveness comparison of sirolimus versus standard treatment in Kasabach-Merritt phenomenon: a real-world evidence study in Thailand.
Tongruang C; Wananukul S; Chatproedprai S; Narkbunnam N; Nitiyarom R; Sirachainan N; Natesirinilkul R; Chaweephisal P; Sosothikul D
Pediatr Hematol Oncol; 2024 Apr; 41(3):229-239. PubMed ID: 38235681
[TBL] [Abstract][Full Text] [Related]
4. Kaposiform Hemangioendothelioma with Bone Destruction: A 16-Year Follow-Up Cohort Study of the Clinical Characteristics and Prognosis.
Qiu T; Zhang Z; Liu J; Zhou J; Gong X; Lan Y; Zhang X; Chen S; Ji Y
J Pediatr Surg; 2024 Apr; 59(4):599-604. PubMed ID: 38158257
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus monotherapy for Kasabach-Merritt phenomenon in a neonate; Case report.
Nakamura S; Ozeki M; Hayashi D; Yasue S; Endo S; Ohnishi H
Int J Surg Case Rep; 2024 Apr; 117():109497. PubMed ID: 38518465
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of kaposiform hemangioendothelioma and capillary malformation: More than a coincidence? Two case reports.
Gong X; Zhou J; Chen S; Ji Y
Heliyon; 2024 Apr; 10(7):e28802. PubMed ID: 38576567
[TBL] [Abstract][Full Text] [Related]
7. Construction and applications of the EOMA spheroid model of Kaposiform hemangioendothelioma.
Li Y; Zhu X; Li L; Bao C; Liu Q; Zhang N; He Z; Ji Y; Bao J
J Biol Eng; 2024 Mar; 18(1):21. PubMed ID: 38486263
[TBL] [Abstract][Full Text] [Related]
8. Refractory kaposiform lymphangiomatosis relieved by splenectomy.
Lan Y; Zhou J; Qiu T; Gong X; Ji Y
Front Pediatr; 2023; 11():1203336. PubMed ID: 37664553
[TBL] [Abstract][Full Text] [Related]
9. Impact of age and tumor size on the development of the Kasabach-Merritt phenomenon in patients with kaposiform hemangioendothelioma: a retrospective cohort study.
Zhou J; Lan Y; Qiu T; Gong X; Zhang Z; He C; Peng Q; Hu F; Zhang X; Lu G; Qiu L; Kong F; Zhang Y; Chen S; Ji Y
Precis Clin Med; 2023 Jun; 6(2):pbad008. PubMed ID: 37305527
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Kaposiform hemangioendothelioma with PIK3CA mutation successfully treated with sirolimus.
Wang Z; Yan H; Ma Y; Yao W; Zheng S; Li K
Front Oncol; 2023; 13():1132702. PubMed ID: 37274236
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of sirolimus treatment for kaposiform hemangioendothelioma: Continuing successes and ongoing challenges.
Zhou J; Li Y; Qiu T; Gong X; Yang K; Zhang X; Zhang Z; Lan Y; Hu F; Peng Q; Zhang Y; Kong F; Chen S; Ji Y
Int J Cancer; 2023 Aug; 153(3):600-608. PubMed ID: 36916140
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
Wang Z; Yao W; Sun H; Dong K; Ma Y; Chen L; Zheng S; Li K
J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702
[TBL] [Abstract][Full Text] [Related]
14. Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma.
Brill R; Uller W; Huf V; Müller-Wille R; Schmid I; Pohl A; Häberle B; Perkowski S; Funke K; Till AM; Lauten M; Neumann J; Güttel C; Heid E; Ziermann F; Schmid A; Hüsemann D; Meyer L; Sporns PB; Schinner R; Schmidt VF; Ricke J; Rössler J; Kapp FG; Wohlgemuth WA; Wildgruber M
Int J Cancer; 2021 May; 148(9):2345-2351. PubMed ID: 33231291
[TBL] [Abstract][Full Text] [Related]
15. Kaposiform hemangioendothelioma: current knowledge and future perspectives.
Ji Y; Chen S; Yang K; Xia C; Li L
Orphanet J Rare Dis; 2020 Feb; 15(1):39. PubMed ID: 32014025
[TBL] [Abstract][Full Text] [Related]
16. [Refractory kaposiforme hemangioendothelioma in the pediatric population: case report and literature review.].
Gómez-Villegas CP; Pérez-Téllez C; Ochoa-Gaviria J; Builes N
Bol Med Hosp Infant Mex; 2021; 78(4):376-384. PubMed ID: 34351887
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
